Delivery Order SPE2DB20D3103-SPE2DB25FQ3N4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) with a ceiling value of $2,257.96. This competitively awarded, firm fixed-price delivery order was executed on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract involves no set-aside designation, and performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,627.83 to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Propranolol ER 80 mg capsules (1,000 count) valued at $1,122.92. This competitive award, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by September 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count) on August 6, 2025, with a ceiling value of $12,757.00 and completion date of August 7, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and specifies Conshohocken, Pennsylvania as the place of performance, which is also the vendor's corporate headquarters location. The delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 120 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,349.13. The award was made on April 25, 2025, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a $15,001.29 delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) under a firm fixed-price contract, with performance scheduled through December 22, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) with a ceiling value of $3,785.24. This competitive award, issued May 6, 2025, with completion by May 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 120 mg capsules (100-count units) with a contract ceiling value of $1,766.04. The award, issued on December 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of December 22, 2025. This is a competitively awarded, non-set-aside contract with performance fulfillment at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Propranolol ER 60 mg capsules in quantities of 100 units. This firm fixed price delivery order, valued at $4,082.40, represents a non-competitive award and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Propranolol ER 120 mg capsules (100 count) with a ceiling value of $1,882.64. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3N4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) on September 17, 2025, with a ceiling value of $2,046.04 and an ultimate completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As a prime vendor under the DLA's pharmaceutical supply chain, the company supplies a comprehensive range of medications and medical commodities to support Defense Health Agency operations and other federal healthcare systems. This delivery order for propranolol, a beta-blocker commonly used in cardiovascular and neurological treatment protocols, exemplifies the company's role in fulfilling routine pharmaceutical requirements across the military healthcare enterprise through its existing IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/17/25 |